Compare ENTX & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTX | SUNS |
|---|---|---|
| Founded | 2010 | 2023 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 128.7M |
| IPO Year | 2018 | N/A |
| Metric | ENTX | SUNS |
|---|---|---|
| Price | $2.08 | $10.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $10.00 | ★ $13.50 |
| AVG Volume (30 Days) | 77.7K | ★ 89.8K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 11.65% |
| EPS Growth | N/A | ★ 1112.46 |
| EPS | N/A | ★ 1.09 |
| Revenue | $124,000.00 | ★ $19,384,703.00 |
| Revenue This Year | N/A | $174.58 |
| Revenue Next Year | N/A | $60.45 |
| P/E Ratio | ★ N/A | $9.44 |
| Revenue Growth | 25.25 | ★ 2540.16 |
| 52 Week Low | $1.50 | $7.80 |
| 52 Week High | $3.22 | $14.87 |
| Indicator | ENTX | SUNS |
|---|---|---|
| Relative Strength Index (RSI) | 32.95 | 57.05 |
| Support Level | $2.07 | $10.06 |
| Resistance Level | $2.22 | $10.45 |
| Average True Range (ATR) | 0.15 | 0.32 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 5.42 | 78.24 |
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.